The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of ipilimumab and nivolumab (ipi/nivo) in metastatic uveal melanoma (UM).
 
Meredith Pelster
Honoraria - Medscape; Medscape (I)
 
Stephen K. Gruschkus
No Relationships to Disclose
 
Roland Bassett
No Relationships to Disclose
 
Dan S. Gombos
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie; Pittman Communications
Travel, Accommodations, Expenses - Abbvie
Other Relationship - 3T Ophthalmics; Aura Biosciences; Castle Biosciences
 
Michael Shephard
No Relationships to Disclose
 
Liberty Posada
No Relationships to Disclose
 
Maura Glover
No Relationships to Disclose
 
Adi Diab
Consulting or Advisory Role - Celgene; CureVac; Nektar
Research Funding - Celgene (Inst); Idera (Inst); Nektar (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Nektar
 
Patrick Hwu
Stock and Other Ownership Interests - Immatics
Consulting or Advisory Role - Dragonfly Therapeutics; GlaxoSmithKline; Immatics; Sanofi
Research Funding - Genentech (Inst)
 
Sapna Pradyuman Patel
Consulting or Advisory Role - Cardinal Health; Castle Biosciences; Incyte
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Castle Biosciences; Incyte; Massachusetts General Hospital; PCME, Rockpointe; Socrates Analytics